Epithelial cell adhesion molecule (EpCAM), also referred to as CD326, is a transmembrane glycoprotein that facilitates Ca2+-independent homotypic cell-cell adhesion in epithelial tissues. Beyond its role in adhesion, EpCAM is integral to various cellular processes including signaling, migration, proliferation, and differentiation. Notably, it possesses oncogenic potential by upregulating key genes such as c-myc, e-fabp, and cyclins A and E. EpCAM is uniquely expressed in epithelial tissues and epithelial-derived neoplasms, making it a valuable diagnostic marker for several cancers. Its involvement in tumorigenesis and metastasis suggests that EpCAM could serve not only as a prognostic marker but also as a target for immunotherapeutic strategies.